Research Article| Volume 40, ISSUE 2, P212-218, February 2004

The human organic anion transporting polypeptide 8 (SLCO1B3) gene is transcriptionally repressed by hepatocyte nuclear factor 3β in hepatocellular carcinoma


      Background/Aims: The organic anion transporting polypeptides (OATPs) mediate the uptake of numerous amphipathic compounds into hepatocytes. Our aim was to study the expression and regulation of OATP8 (OATP1B3, SLC21A8/SLCO1B3) and OATP-C (OATP1B1, SLC21A6/SLCO1B1) in hepatocellular carcinomas (HCC).
      Methods: RNA and protein levels in 13 paired HCC and adjacent non-tumor liver samples were quantified by real-time polymerase chain reaction or Western blot, respectively. The OATP8 and OATP-C gene promoters were characterized by luciferase reporter assays and electrophoretic mobility shift assays (EMSA).
      Results: The expression of OATP8 was decreased in 60% of HCC compared to surrounding non-tumor liver tissue, on both the mRNA and protein levels. Expression of the liver-enriched transcription factor hepatocyte nuclear factor 3β (HNF3β) was increased in 70% of HCC and correlated inversely with OATP8 mRNA (r=−0.75, P<0.05) and protein. In contrast to OATP8, expression of OATP-C was not significantly decreased in HCC. In transfected Huh7 cells, OATP8 promoter activity was inhibited by 70% when HNF3β was cotransfected. An HNF3β binding site was located at nt −39/−23 by EMSA. The OATP-C promoter was not inhibited by HNF3β.
      Conclusions: HNF3β represses transcription of the OATP8 but not the OATP-C gene, providing a mechanism for reduced expression of OATP8 in HCC.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hagenbuch B.
        • Meier P.J.
        The superfamily of organic anion transporting polypeptides.
        Biochim Biophys Acta. 2003; 1609: 1-18
        • Kullak-Ublick G.A.
        • Stieger B.
        • Hagenbuch B.
        • Meier P.J.
        Hepatic transport of bile salts.
        Semin Liver Dis. 2000; 20: 273-292
        • Abe T.
        • Kakyo M.
        • Tokui T.
        • Nakagomi R.
        • Nishio T.
        • Nakai D.
        • et al.
        Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1.
        J Biol Chem. 1999; 274: 17159-17163
        • Hsiang B.
        • Zhu Y.
        • Wang Z.
        • Wu Y.
        • Sasseville V.
        • Yang W.-P.
        • et al.
        A novel human hepatic organic anion transporting polypeptide (OATP2).
        J Biol Chem. 1999; 274: 37161-37168
        • König J.
        • Cui Y.
        • Nies A.T.
        • Keppler D.
        A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane.
        Am J Physiol. 2000; 278: G156-G164
        • Kullak-Ublick G.A.
        • Ismair M.G.
        • Stieger B.
        • Landmann L.
        • Huber R.
        • Pizzagalli F.
        • et al.
        Organic anion transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.
        Gastroenterology. 2001; 120: 525-533
        • Cui Y.
        • König J.
        • Leier I.
        • Buchholz U.
        • Keppler D.
        Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.
        J Biol Chem. 2001; 276: 9626-9630
        • König J.
        • Cui Y.
        • Nies A.T.
        • Keppler D.
        Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide.
        J Biol Chem. 2000; 275: 23161-23168
        • Ismair M.G.
        • Stieger B.
        • Cattori V.
        • Hagenbuch B.
        • Fried M.
        • Meier P.J.
        • et al.
        Hepatic uptake of cholecystokinin octapeptide by organic anion transporting polypeptides Oatp4 and OATP8 of rat and human liver.
        Gastroenterology. 2001; 121: 1185-1190
        • Abe T.
        • Unno M.
        • Onogawa T.
        • Tokui T.
        • Kondo T.N.
        • Nakagomi R.
        • et al.
        Lst-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.
        Gastroenterology. 2001; 120: 1689-1699
        • Jung D.
        • Hagenbuch B.
        • Gresh L.
        • Pontoglio M.
        • Meier P.J.
        • Kullak-Ublick G.A.
        Characterization of the human OATP-C (SLC21A6) gene promoter and regulation of liver-specific OATP genes by hepatocyte nuclear factor 1α.
        J Biol Chem. 2001; 276: 37206-37214
        • Jung D.
        • Kullak-Ublick G.A.
        Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression.
        Hepatology. 2003; 37: 622-631
        • Jung D.
        • Podvinec M.
        • Meyer U.A.
        • Mangelsdorf D.J.
        • Fried M.
        • Meier P.J.
        • et al.
        Human organic anion transporting polypeptide 8 promoter is transactivated by the farnesoid X receptor/bile acid receptor.
        Gastroenterology. 2002; 122: 1954-1966
        • Karpen S.J.
        • Sun A.-Q.
        • Kudish B.
        • Hagenbuch B.
        • Meier P.J.
        • Ananthanarayanan M.
        • et al.
        Multiple factors regulate the rat liver basolateral sodium-dependent bile acid cotransporter gene promoter.
        J Biol Chem. 1996; 271: 15211-15221
        • Rausa F.M.
        • Tan Y.
        • Zhou H.
        • Yoo K.W.
        • Stolz D.B.
        • Watkins S.C.
        • et al.
        Elevated levels of hepatocyte nuclear factor 3beta in mouse hepatocytes influence expression of genes involved in bile acid and glucose homeostasis.
        Mol Cell Biol. 2000; 20: 8264-8282
        • Tan Y.
        • Hughes D.
        • Wang X.
        • Costa R.H.
        Adenovirus-mediated increase in HNF-3beta or HNF-3alpha shows differences in levels of liver glycogen and gene expression.
        Hepatology. 2002; 35: 30-39
        • Xu L.
        • Hui L.
        • Wang S.
        • Gong J.
        • Jin Y.
        • Wang Y.
        • et al.
        Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
        Cancer Res. 2001; 61: 3176-3181
        • Kaestner K.H.
        The hepatocyte nuclear factor 3 (HNF3 or FOXA) family in metabolism.
        Trends Endocrinol Metab. 2000; 11: 281-285
        • Pani L.
        • Overdier D.G.
        • Porcella A.
        • Qian X.
        • Lai E.
        • Costa R.H.
        Hepatocyte nuclear factor 3β contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein.
        Mol Cell Biol. 1992; 12: 3723-3732
        • Schrem H.
        • Klempnauer J.
        • Borlak J.
        Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression.
        Pharmacol Rev. 2002; 54: 129-158
        • Vallet V.
        • Antoine B.
        • Chafey P.
        • Vandewalle A.
        • Kahn A.
        Overproduction of a truncated hepatocyte nuclear factor 3 protein inhibits expression of liver-specific genes in hepatoma cells.
        Mol Cell Biol. 1995; 15: 5453-5460
        • Cui Y.
        • König J.
        • Nies A.T.
        • Pfannschmidt M.
        • Hergt M.
        • Franke W.W.
        • et al.
        Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma.
        Lab Invest. 2003; 83: 527-538
        • Dignam J.D.
        • Lebovitz R.M.
        • Roeder R.G.
        Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
        Nucleic Acids Res. 1983; 11: 1475-1489
        • Zaret K.S.
        Molecular genetics of early liver development.
        Annu Rev Physiol. 1996; 58: 231-251
        • Sund N.J.
        • Ang S.L.
        • Sackett S.D.
        • Shen W.
        • Daigle N.
        • Magnuson M.A.
        • et al.
        Hepatocyte nuclear factor 3beta (Foxa2) is dispensable for maintaining the differentiated state of the adult hepatocyte.
        Mol Cell Biol. 2000; 20: 5175-5183
        • Ang S.L.
        • Rossant J.
        HNF-3 beta is essential for node and notochord formation in mouse development.
        Cell. 1994; 78: 561-574
        • Dufort D.
        • Schwartz L.
        • Harpal K.
        • Rossant J.
        The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis.
        Development. 1998; 125: 3015-3025
        • Duncan S.A.
        • Navas M.A.
        • Dufort D.
        • Rossant J.
        • Stoffel M.
        Regulation of a transcription factor network required for differentiation and metabolism.
        Science. 1998; 281: 692-695
        • Stenson-Cox C.
        • McNair A.
        • Curley M.
        • Smith T.
        • Gannon F.
        A role for HNF-3 in the regulation of the HNF-1 gene of the Atlantic salmon.
        Mol Genet Genomics. 2002; 266: 832-837
        • Philippe J.
        • Morel C.
        • Prezioso V.R.
        Glucagon gene expression is negatively regulated by hepatocyte nuclear factor 3 beta.
        Mol Cell Biol. 1994; 14: 3514-3523
        • Gregori C.
        • Kahn A.
        • Pichard A.L.
        Activity of the rat liver-specific aldolase B promoter is restrained by HNF3.
        Nucleic Acids Res. 1994; 22: 1242-1246
        • Cooper A.D.
        • Chen J.
        • Botelho-Yetkinler M.J.
        • Cao Y.
        • Taniguchi T.
        • Levy-Wilson B.
        Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7α-hydroxylase gene.
        J Biol Chem. 1997; 272: 3444-3452
        • Kullak-Ublick G.A.
        • Glasa J.
        • Boeker C.
        • Oswald M.
        • Gruetzner U.
        • Hagenbuch B.
        • et al.
        Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas.
        Gastroenterology. 1997; 113: 1295-1305
        • Tirona R.G.
        • Kim R.B.
        Pharmacogenomics of organic anion-transporting polypeptides (OATP).
        Adv Drug Deliv Rev. 2002; 54: 1343-1352
        • van Montfoort J.E.
        • Stieger B.
        • Meijer D.K.F.
        • Weinmann H.-J.
        • Meier P.J.
        • Fattinger K.E.
        Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1.
        J Pharmacol Exp Ther. 1999; 290: 153-157
        • Pascolo L.
        • Cupelli F.
        • Anelli P.L.
        • Lorusso V.
        • Visigalli M.
        • Uggeri F.
        • et al.
        Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.
        Biochem Biophys Res Commun. 1999; 257: 746-752
        • Monte M.J.
        • Dominguez S.
        • Palomero M.F.
        • Macias R.I.R.
        • Marin J.J.G.
        Further evidence of the usefulness of bile acids as molecules for shuttling cytostatic drugs toward liver tumors.
        J Hepatol. 1999; 31: 521-528
        • Dominguez M.F.
        • Macias R.I.
        • Izco Basurko I.
        • de La Fuente A.
        • Pascual M.J.
        • Criado J.M.
        • et al.
        Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
        J Pharmacol Exp Ther. 2001; 297: 1106-1112
        • Larena M.G.
        • Martinez Diez M.C.
        • Monte M.J.
        • Dominguez M.F.
        • Pascual M.J.
        • Marin J.J.
        Liver organotropism and biotransformation of a novel platinum-ursodeoxycholate derivative, Bamet-UD2, with enhanced antitumour activity.
        J Drug Target. 2001; 9: 185-200
        • Briz O.
        • Serrano M.A.
        • Rebollo N.
        • Hagenbuch B.
        • Meier P.J.
        • Koepsell H.
        • et al.
        Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum (II) and cis-diammine-bisursodeoxycholate-platinum (II) toward liver cells.
        Mol Pharmacol. 2002; 61: 853-860